Caribou Biosciences Inc (CRBU) Directors and Executive Officers

Officers & Directors

Jason V. O Byrne
Chief Financial Officer (Principal Financial Officer)

Scott Braunstein
Director

Natalie R. Sacks
Director

Andrew Guggenhime
Director

Rachel E. Haurwitz
President and Chief Executive Officer (Principal Executive Officer)

David Johnson
Director

Nancy Whiting
Director

Dara Richardson-Heron
Director

Ran Zheng
Director,

Caribou Biosciences Inc currently has 97 employees.

News about Caribou Biosciences Inc Key Personnel

Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025

Caribou Biosciences Faces Legal and Financial Storm While Advancing Groundbreaking TrialsIn a landscape characterized by rapid advancements in biotechnology, Caribou Biosciences, Inc. (NASDAQ: CRBU) finds itself at a critical crossroads, navigating through a maelstrom of legal challenges and mounting financial difficulties even as it embarks on game-changing clinical trials. The company s recent initiation of the CB-010 GALLOP Phase 1 study in lupus, and progress in its CB-012 AMpLify Phase 1 trial for relapsed/refractory acute myeloid leukemia (r/r AML), underscores its commitment to unlocking the potential of genome editing. However, this commitment is shadowed by a deteriorating financial outlook and a s...

Caribou Biosciences Strengthens Clinical Development with Appointment of Dr. Tina Albertson as Chief Medical Officer,

Caribou Biosciences Appoints Highly-Experienced Hematologist and Oncologist, Dr. Tina Albertson, as Chief Medical Officer
Berkeley, Calif., Aug. 12, 2024 - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, has recently announced the appointment of Dr. Tina Albertson, MD, PhD, as the new chief medical officer. With an impressive background in leading clinical drug development of cellular therapies and biologics spanning over 15 years, Dr. Albertson brings a wealth of experience to Caribou Biosciences. In her new role, she will oversee the strategic leadership of clinical, regulatory, and medical functions, as well as provide operational lea...